Awards Support Innovative Prostate Cancer Research
The Robert H. Lurie Comprehensive Cancer Center’s SPORE in Prostate Cancer and Polsky Urologic Cancer Institute announce the following awards in support of innovative prostate cancer research:
Polsky Urologic Cancer Institute Awards
 |
Sarki Abdulkadir, MD, PhD |
 |
Gary Schiltz, PhD |
 |
"Gender Differences in Mechanisms of Smoking-Related Carcinogenesis" Joshua Meeks, MD, PhD |
|
|
"Developing Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification" Ashley Ross, MD, PhD |
|
"Delineating Super-Enhancer-Regulated lncRNA Drivers in Metastatic Prostate Cancer" Rendong Yang, PhD |
|
 |
"Targeting Metabolic Adaptation to Treat TP53-mutated Lethal Prostate Cancer" Young Yoo, PhD |
Lurie Cancer Center's SPORE in Prostate Cancer Awards
 |
"Epigenome-focused CRISPR screen for hormone sensitive and castrate resistant prostate cancers" Debabrata (Debu) Chakravarti, PhD Obstetrics and Gynecology; Pharmacology |
 |
"Targeting Plek2 for the treatment of prostate cancer" Peng Ji, MD, PhD |
 |
"Metabolic and Cytoskeletal Regulation of Cell Proliferation and Metastasis in Prostate Cancer" Dileep Varma, PhD |
 |
"Role of FOXA2 in inducing lineage plasticity and prostate cancer progression" Jindan Yu, MD, PhD |
 |
"Discovery and development of molecular glue degraders targeting androgen receptor splice variants driven prostate cancer" Xiaoyu Zhang, PhD |
 |
"Activating the NLRP3 Inflammasome to Treat Advanced Prostate Cancer" Akash Patnaik, MD, PhD (University of Chicago) |
 |
"WEE1 is a novel therapeutic target to overcome SOX2-mediated androgen receptor signaling inhibitor (ARSI) resistance in prostate cancer" Russell Szmulewitz, MD (University of Chicago) |
 |
"The role of ZCCHC7 in advanced prostate cancer" Qi Cao, PhD |
 |
"Role of BAP1 complexes in prostate cancer" Lu Wang, PhD |
 |
"Whole-genome Structural Variation and CpG methylation Analyses through Long-Read Sequencing" Changsheng (Jonathan) Zhao, MD |